10-43124887-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020975.6(RET):​c.2944C>T​(p.Arg982Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0164 in 1,613,854 control chromosomes in the GnomAD database, including 372 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R982S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.017 ( 30 hom., cov: 33)
Exomes 𝑓: 0.016 ( 342 hom. )

Consequence

RET
NM_020975.6 missense

Scores

1
3
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:35O:2

Conservation

PhyloP100: 1.17

Publications

73 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009423137).
BP6
Variant 10-43124887-C-T is Benign according to our data. Variant chr10-43124887-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 13938.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0165 (2520/152304) while in subpopulation SAS AF = 0.0402 (194/4830). AF 95% confidence interval is 0.0355. There are 30 homozygotes in GnomAd4. There are 1224 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.2944C>Tp.Arg982Cys
missense
Exon 18 of 20NP_066124.1P07949-1
RET
NM_001406743.1
c.2944C>Tp.Arg982Cys
missense
Exon 18 of 21NP_001393672.1P07949-1
RET
NM_001406744.1
c.2944C>Tp.Arg982Cys
missense
Exon 18 of 20NP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.2944C>Tp.Arg982Cys
missense
Exon 18 of 20ENSP00000347942.3P07949-1
RET
ENST00000340058.6
TSL:1
c.2944C>Tp.Arg982Cys
missense
Exon 18 of 19ENSP00000344798.4P07949-2
RET
ENST00000713926.1
c.2680C>Tp.Arg894Cys
missense
Exon 18 of 19ENSP00000519223.1A0AAQ5BH28

Frequencies

GnomAD3 genomes
AF:
0.0165
AC:
2514
AN:
152186
Hom.:
30
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0149
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0225
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.0156
Gnomad SAS
AF:
0.0397
Gnomad FIN
AF:
0.00528
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0157
Gnomad OTH
AF:
0.0240
GnomAD2 exomes
AF:
0.0192
AC:
4838
AN:
251460
AF XY:
0.0205
show subpopulations
Gnomad AFR exome
AF:
0.0138
Gnomad AMR exome
AF:
0.0139
Gnomad ASJ exome
AF:
0.0336
Gnomad EAS exome
AF:
0.0141
Gnomad FIN exome
AF:
0.00684
Gnomad NFE exome
AF:
0.0171
Gnomad OTH exome
AF:
0.0200
GnomAD4 exome
AF:
0.0163
AC:
23888
AN:
1461550
Hom.:
342
Cov.:
31
AF XY:
0.0171
AC XY:
12431
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.0152
AC:
510
AN:
33468
American (AMR)
AF:
0.0147
AC:
656
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0340
AC:
889
AN:
26134
East Asian (EAS)
AF:
0.00796
AC:
316
AN:
39698
South Asian (SAS)
AF:
0.0425
AC:
3661
AN:
86226
European-Finnish (FIN)
AF:
0.00695
AC:
371
AN:
53400
Middle Eastern (MID)
AF:
0.0376
AC:
210
AN:
5590
European-Non Finnish (NFE)
AF:
0.0145
AC:
16154
AN:
1111940
Other (OTH)
AF:
0.0186
AC:
1121
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
1350
2699
4049
5398
6748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0165
AC:
2520
AN:
152304
Hom.:
30
Cov.:
33
AF XY:
0.0164
AC XY:
1224
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0149
AC:
621
AN:
41570
American (AMR)
AF:
0.0225
AC:
344
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3472
East Asian (EAS)
AF:
0.0158
AC:
82
AN:
5174
South Asian (SAS)
AF:
0.0402
AC:
194
AN:
4830
European-Finnish (FIN)
AF:
0.00528
AC:
56
AN:
10612
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0158
AC:
1072
AN:
68030
Other (OTH)
AF:
0.0242
AC:
51
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
127
253
380
506
633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0168
Hom.:
111
Bravo
AF:
0.0169
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0156
AC:
60
ESP6500AA
AF:
0.0159
AC:
70
ESP6500EA
AF:
0.0164
AC:
141
ExAC
AF:
0.0192
AC:
2335
Asia WGS
AF:
0.0370
AC:
129
AN:
3478
EpiCase
AF:
0.0190
EpiControl
AF:
0.0194

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
10
not specified (11)
-
-
5
not provided (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
Multiple endocrine neoplasia, type 2 (3)
-
-
2
Multiple endocrine neoplasia (2)
-
1
1
Multiple endocrine neoplasia type 2A (2)
-
-
2
Multiple endocrine neoplasia type 2B (2)
-
-
2
Pheochromocytoma (2)
-
1
-
Aganglionic megacolon (1)
-
-
1
Breast-ovarian cancer, familial, susceptibility to, 1 (1)
-
-
1
Familial medullary thyroid carcinoma (1)
-
-
1
Hirschsprung disease, susceptibility to, 1 (2)
-
-
1
Malignant tumor of breast (1)
-
-
1
Multiple endocrine neoplasia type 2A;C0025269:Multiple endocrine neoplasia type 2B;C0031511:Pheochromocytoma;C1833921:Familial medullary thyroid carcinoma;C3888239:Hirschsprung disease, susceptibility to, 1 (1)
-
-
1
Renal hypodysplasia/aplasia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
D
Eigen
Benign
-0.081
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.78
T
MetaRNN
Benign
0.0094
T
MetaSVM
Uncertain
-0.15
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.2
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-3.5
D
REVEL
Benign
0.28
Sift
Benign
0.058
T
Sift4G
Benign
0.072
T
Polyphen
1.0
D
Vest4
0.088
MPC
0.88
ClinPred
0.028
T
GERP RS
-0.30
Varity_R
0.51
gMVP
0.25
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17158558; hg19: chr10-43620335; COSMIC: COSV60696488; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.